ALT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Altimmune Inc

NASDAQ | ALT

4.64

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 21, 2025)

$478.93M

Market Cap

-

P/E Ratio

-1.07

EPS

$10.88

52 Week High

$2.90

52 Week Low

HEALTHCARE

Sector

ALT Chart

Recent Chart
Price Action

ALT Technicals

Tags:

ALT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20K
Total Revenue $20K
Cost Of Revenue $238K
Costof Goods And Services Sold $238K
Operating Income -$103M
Selling General And Administrative $21M
Research And Development $82M
Operating Expenses $103M
Investment Income Net -
Net Interest Income $8.1M
Interest Income $8.1M
Interest Expense $9K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $238K
Income Before Tax -$95M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$95M
Comprehensive Income Net Of Tax -
Ebit -$95M
Ebitda -$95M
Net Income -$95M

Revenue & Profitability

Earnings Performance

ALT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $139M
Total Current Assets $137M
Cash And Cash Equivalents At Carrying Value $37M
Cash And Short Term Investments $37M
Inventory -
Current Net Receivables $3.1M
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $95M
Other Current Assets $2.2M
Other Non Current Assets -
Total Liabilities $16M
Total Current Liabilities $10M
Current Accounts Payable $211K
Deferred Revenue -
Current Debt -
Short Term Debt $279K
Total Non Current Liabilities $5.3M
Capital Lease Obligations $1.7M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7M
Other Current Liabilities $10M
Other Non Current Liabilities $3.9M
Total Shareholder Equity $124M
Treasury Stock -
Retained Earnings -$561M
Common Stock $7K
Common Stock Shares Outstanding $71M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$80M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $238K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$28M
Cashflow From Financing $10M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $300K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$95M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20K
Total Revenue $20K
Cost Of Revenue $238K
Costof Goods And Services Sold $238K
Operating Income -$103M
Selling General And Administrative $21M
Research And Development $82M
Operating Expenses $103M
Investment Income Net -
Net Interest Income $8.1M
Interest Income $8.1M
Interest Expense $9K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $238K
Income Before Tax -$95M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$95M
Comprehensive Income Net Of Tax -
Ebit -$95M
Ebitda -$95M
Net Income -$95M

Dividends

Field Value
Ex Dividend Date 2017-02-06
Declaration Date None
Record Date None
Payment Date None
Amount 2.91

ALT News

ALT Profile

Altimmune Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Altimmune, Inc. is a prominent clinical-stage biopharmaceutical company headquartered in Gaithersburg, Maryland, specializing in the development of intranasal vaccines and immunomodulatory therapies to address urgent unmet medical needs. Utilizing its proprietary technology platforms, Altimmune is advancing a diverse pipeline focused on infectious diseases and liver disorders, aiming to redefine therapeutic solutions in these critical areas. With a robust commitment to research and development, the company is well-positioned to deliver transformative innovations that enhance patient care and solidify its competitive edge within the rapidly evolving biopharmaceutical sector.

LPTX
+368.57%
$2.05
NVVE
+56.73%
$0.25
IVP
+29.19%
$0.16
NVDA
-0.21%
$180.25
VHAI
-50.00%
$0.00
IVDA
+33.58%
$0.86
OSRH
+28.11%
$0.58
DVLT
+39.08%
$2.42
SGBX
-37.06%
$3.82
NWTN
+41.76%
$0.78
ONDS
+2.38%
$6.41
AXDX
-61.36%
$0.03
TSLA
+0.11%
$395.68
PLUG
+1.85%
$1.92
ASST
+1.59%
$0.99
SOFI
+0.06%
$24.92
CCTG
+41.01%
$0.23
MNDR
+39.13%
$4.22
BITF
-8.84%
$2.37
INTC
+1.35%
$34.07
ADAP
-15.14%
$0.05
BYND
-2.75%
$0.85
DNN
-2.37%
$2.26
PLTR
-1.13%
$153.97
GRAB
-1.60%
$4.90
AMD
-1.51%
$202.89
PFE
+4.06%
$25.39
GOOGL
+3.00%
$298.15
TLRY
-6.53%
$0.89
AMZN
+0.79%
$218.86
AAL
+5.51%
$12.91
QBTS
-12.50%
$20.51
CIFR
-4.57%
$13.89
RMBL
+60.50%
$3.21
BMNR
+0.05%
$26.03
F
+3.27%
$12.81
LNW
-3.71%
$86.22
IREN
-2.78%
$42.26
ADD
-25.47%
$0.05
AIIO
+17.94%
$0.92
BBD
+0.57%
$3.50
MARA
-2.09%
$10.02
T
+2.12%
$26.06
ACHR
+2.98%
$7.07
SRM
+53.27%
$10.30
NFE
-17.03%
$1.21
RGTI
-0.65%
$22.65
NIO
+3.70%
$5.60
FOXX
+71.44%
$3.46
SOND
-13.27%
$0.14
NOK
+0.88%
$5.92
SOUN
-1.07%
$11.16
WULF
-2.63%
$11.25
AAPL
+1.82%
$271.10
IONZ
+3.11%
$6.62
ORCL
-6.24%
$197.53
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
CRWV
+1.63%
$70.34
GPUS
+13.27%
$0.23
CSCO
-3.76%
$75.44
NBIS
-1.27%
$83.56
BMNU
-1.02%
$5.31
HOOD
+1.24%
$107.53
RIVN
+0.37%
$14.71
BULL
+1.29%
$8.35
BTBT
+0.48%
$2.06
GOOG
+2.49%
$297.22
SNAP
-0.57%
$7.73
PLTZ
+1.17%
$8.57
BURU
+5.25%
$0.19
APLD
-4.11%
$20.49
PLTD
+0.58%
$7.67
QS
-2.94%
$11.37
AFMD
-34.94%
$0.18
RIG
+0.26%
$3.85
RXRX
+7.24%
$4.12
WMT
-1.58%
$105.41
VALE
+0.75%
$12.01
MU
+2.33%
$206.07
IONQ
-1.84%
$40.24
BAC
+0.73%
$51.37
BE
-14.27%
$93.38
CGC
+3.70%
$1.04
JOBY
-1.00%
$12.90
CAN
-0.21%
$0.92
SMCI
+1.45%
$32.02
GRYP
-10.38%
$1.38
ABEV
+1.85%
$2.47
MODV
-25.22%
$0.43
WBD
+1.28%
$23.17
AMC
+3.14%
$2.13
UBER
+0.13%
$83.47
ETHE
-3.76%
$23.25
MSTR
-1.42%
$174.60
EOSE
-4.42%
$12.31
CYPH
-21.25%
$2.31
BBWI
-5.46%
$14.95
KDLY
-9.57%
$0.48
CLSK
-2.91%
$9.49
LPTX
+368.57%
$2.05
NVVE
+56.73%
$0.25
IVP
+29.19%
$0.16
NVDA
-0.21%
$180.25
VHAI
-50.00%
$0.00
IVDA
+33.58%
$0.86
OSRH
+28.11%
$0.58
DVLT
+39.08%
$2.42
SGBX
-37.06%
$3.82
NWTN
+41.76%
$0.78
ONDS
+2.38%
$6.41
AXDX
-61.36%
$0.03
TSLA
+0.11%
$395.68
PLUG
+1.85%
$1.92
ASST
+1.59%
$0.99
SOFI
+0.06%
$24.92
CCTG
+41.01%
$0.23
MNDR
+39.13%
$4.22
BITF
-8.84%
$2.37
INTC
+1.35%
$34.07
ADAP
-15.14%
$0.05
BYND
-2.75%
$0.85
DNN
-2.37%
$2.26
PLTR
-1.13%
$153.97
GRAB
-1.60%
$4.90
AMD
-1.51%
$202.89
PFE
+4.06%
$25.39
GOOGL
+3.00%
$298.15
TLRY
-6.53%
$0.89
AMZN
+0.79%
$218.86
AAL
+5.51%
$12.91
QBTS
-12.50%
$20.51
CIFR
-4.57%
$13.89
RMBL
+60.50%
$3.21
BMNR
+0.05%
$26.03
F
+3.27%
$12.81
LNW
-3.71%
$86.22
IREN
-2.78%
$42.26
ADD
-25.47%
$0.05
AIIO
+17.94%
$0.92
BBD
+0.57%
$3.50
MARA
-2.09%
$10.02
T
+2.12%
$26.06
ACHR
+2.98%
$7.07
SRM
+53.27%
$10.30
NFE
-17.03%
$1.21
RGTI
-0.65%
$22.65
NIO
+3.70%
$5.60
FOXX
+71.44%
$3.46
SOND
-13.27%
$0.14
NOK
+0.88%
$5.92
SOUN
-1.07%
$11.16
WULF
-2.63%
$11.25
AAPL
+1.82%
$271.10
IONZ
+3.11%
$6.62
ORCL
-6.24%
$197.53
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
CRWV
+1.63%
$70.34
GPUS
+13.27%
$0.23
CSCO
-3.76%
$75.44
NBIS
-1.27%
$83.56
BMNU
-1.02%
$5.31
HOOD
+1.24%
$107.53
RIVN
+0.37%
$14.71
BULL
+1.29%
$8.35
BTBT
+0.48%
$2.06
GOOG
+2.49%
$297.22
SNAP
-0.57%
$7.73
PLTZ
+1.17%
$8.57
BURU
+5.25%
$0.19
APLD
-4.11%
$20.49
PLTD
+0.58%
$7.67
QS
-2.94%
$11.37
AFMD
-34.94%
$0.18
RIG
+0.26%
$3.85
RXRX
+7.24%
$4.12
WMT
-1.58%
$105.41
VALE
+0.75%
$12.01
MU
+2.33%
$206.07
IONQ
-1.84%
$40.24
BAC
+0.73%
$51.37
BE
-14.27%
$93.38
CGC
+3.70%
$1.04
JOBY
-1.00%
$12.90
CAN
-0.21%
$0.92
SMCI
+1.45%
$32.02
GRYP
-10.38%
$1.38
ABEV
+1.85%
$2.47
MODV
-25.22%
$0.43
WBD
+1.28%
$23.17
AMC
+3.14%
$2.13
UBER
+0.13%
$83.47
ETHE
-3.76%
$23.25
MSTR
-1.42%
$174.60
EOSE
-4.42%
$12.31
CYPH
-21.25%
$2.31
BBWI
-5.46%
$14.95
KDLY
-9.57%
$0.48
CLSK
-2.91%
$9.49
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.